Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The American Journal of Pathology|January 4, 2014
Regulation of the histamine/VEGF axis by miR-125b during cholestatic liver injury in miceFanyin Meng, Paolo Onori, Laura Hargrove, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 30, 2014
Knockout of histidine decarboxylase decreases bile duct ligation-induced biliary hyperplasia via downregulation of the histidine decarboxylase/VEGF axis through PKA-ERK1/2 signalingAllyson Graf, Fanyin Meng, Laura Hargrove, et al.
Hepatology (Baltimore, Md.)|August 8, 2020
Mast Cells Induce Ductular Reaction Mimicking Liver Injury in Mice Through Mast Cell-Derived Transforming Growth Factor Beta 1 SignalingKonstantina Kyritsi, Lindsey Kennedy, Vik Meadows, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 15, 2020
Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signalingLindsey Kennedy, Vik Meadows, Jennifer Demieville, et al.
Hepatology (Baltimore, Md.)|June 29, 2016
Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) miceHannah Jones, Laura Hargrove, Lindsey Kennedy, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 16, 2019
Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2-/- miceVik Meadows, Lindsey Kennedy, Laura Hargrove, et al.
The American Journal of Pathology|March 7, 2020
Amelioration of Large Bile Duct Damage by Histamine-2 Receptor Vivo-Morpholino TreatmentLindsey Kennedy, Vik Meadows, Konstantina Kyritsi, et al.
Hepatology (Baltimore, Md.)|June 24, 2021
Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor SignalingVik Meadows, Lindsey Kennedy, Burcin Ekser, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 26, 2018
Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2-/- mice and human primary sclerosing cholangitisFanyin Meng, Lindsey Kennedy, Laura Hargrove, et al.
Hepatology (Baltimore, Md.)|March 31, 2018
Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2-/- mice and human cholangiocarcinoma tumorigenesisLindsey Kennedy, Laura Hargrove, Jennifer Demieville, et al.
Pageof 3